期刊名称：PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
 The role of lipids, including essential fatty acids and their prostaglandin, leukotriene and other derivatives, is now evident in almost all areas of biomedical science. Cell membrane behaviour and cell signalling in all tissues are highly dependent on the lipid constituents of cells. Prostaglandins, Leukotrienes and Essential Fatty Acids aims to cover all aspects of the roles of lipids in cellular, organ and whole organism function, and places a particular emphasis on human studies. Papers concerning all medical specialties are published. Much of the material is particularly relevant to the development of novel treatments for disease.
| |
Instructions to Authors
Please direct all general correspondence to the Editorial Office. Authors who wish to submit mini-reviews or reviews, or those who would like to organise special issues should contact the Editor-in-Chief with their proposals. From early 2004 we encourage manuscripts to be submitted electronically via our online submission and peer-review tool (see http://authors.elsevier.com/journal/plefa).
Rob Webb
PLEFA Editorial Office
Elsevier
The Boulevard
Langford Lane
Kidlington
Oxford OX5 3BL
UK
Tel: +44 (0)1865 843033
Fax: +44 (0)1865 843915
Email: plefa@elsevier.com
Mehar Manku
PLEFA Editor-in-Chief
Amarin Neuroscience Ltd
Kings Park House
Laurelhill Business Park
Polmaise Road
Stirling FK7 9JO
UK
Fax: +44 (0)1786 473137
Email: MManku@laxdale.co.uk
Papers should be submitted in journal style. Failure to do so may lead to significant delays in publication. Spelling may be British or American. Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. In an accompanying letter, the authors should state that they contributed to the manuscript and that they agree to the corresponding author acting on their behalf.
The Editors reserve the right to make editorial and literary corrections. Any opinions expressed or policies advocated do not necessarily reflect the opinions or policies of the Editors.
Typescripts that contain the results of human and/or animal studies will be accepted for publication only if it is made clear that a high standard of ethics was applied in carrying out the investigations. In the case of invasive studies in humans, typescripts should include a statement that the research protocol was approved by a local ethical committee.
These instructions are in accordance with the International Committee of Medical Journal Editors, Uniform requirements for manuscripts submitted to biomedical journals BMJ 302 (1991) 338-341.
Conflict of interest statement
All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work, all within 3 years of beginning the work submitted. If there are no conflicts of interest, authors should state that there are none.
Presentation of Manuscripts
Papers should be set out as follows, with each section beginning on a new page: title page, summary, text, acknowledgements, references, tables, captions to illustrations. The title page should give the following information: (1) title of the article, (2) initials and surname of each author, (3) name and address of the department or institution to which the work should be attributed, (4) name, address, telephone, fax number and e-mail address of the author responsible for correspondence and to whom requests for offprints should be sent and (5) sources of support in the form of grants.
Authors may suggest three potential reviewers by submitting relevant names, postal addresses and email addresses.
The summary should consist of not more than 150 words summarising the contents of the article. The text should be arranged as follows: (1) Introduction, (2) Patients and Methods, or Materials and Methods, (3) Results, (4) Discussion and Conclusions and (5) Acknowledgements.
Other papers can be sub-divided as the author desires: the use of headings in such papers enhances readability. Normally only two categories of headings should be used. Major headings should be in capital letters in the centre of the page and underlined. Minor ones should be typed in lower case with an initial capital letter and underlined. Each page, including the first, should be numbered.
Do not use 'he', 'his', etc where the sex of the person is unknown: say 'the patient', etc. Avoid inelegant alternatives such as 'he/she'. Patients should not be automatically designated as 'she', and doctors as 'he'.
Comments
Comments provide an opportunity for discussion of previously published papers or reviews. The title, authors' names and reference of the article on which comments are being made should be clearly noted at the top. This should be followed by 'Comments by ?' and the name(s) and address(es) of the writer(s). Comments are strictly limited to two manuscript pages.
Reference Format
The accuracy of references is the responsibility of the author. References should be entered in the text as numbers within square brackets. The reference list should be listed in numerical order in a separate section. References to journals should include the author's initials and surname (list all authors when six or fewer when seven or more, list only the first three and add et al.), full title of paper, journal title abbreviated, using Index Medicus abbreviations, year of publication, volume number, first and last page numbers. For example:
1. M. Miller-Anderson, H. Borg, L.O. Anderson, Purification of antithrombin III by affinity chromatography, Thromb Res 5 (1974) 439-452.
References to books should be set out as follows:
2. P. Wallen, Chemistry of plasminogen activation, in: J.F. Davidson (Ed.), Progress in Chemical Fibrinolysis and Thrombolysis, Raven Press, New York, 1978, pp. 167-181.
Figures
Line Illustrations
All line illustrations should present a crisp black image on an even white background.
Photographic Illustrations and Radiographs
These should be submitted as clear, lightly contrasted black and white prints or files. Photomicrographs should have the magnification and details of staining techniques shown. X-ray films should be submitted as photographic prints or files, carefully made to bring out the details to be illustrated. All hardcopy illustrations should be clearly marked (by a label pasted on the back or by a soft crayon) with figure number and author's name, and the top of the figure should be indicated by an arrow. Never use ink of any kind. Do not use paper clips as these can scratch or mark illustrations. Captions should be in a separate section of the manuscript following the references.
Use of Colour
If, together with your accepted article, you submit usable colour figures then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. For further information on the preparation of electronic artwork, please see http://authors.elsevier.com/artwork.
Please note: Because of technical complications which can arise by converting colour figures to 'grey scale' (for the printed version should you not opt for colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.
Permission to reproduce borrowed illustrations or tables or identifiable clinical photographs
Written permission to reproduce borrowed material (illustrations and tables) must be obtained from the original publishers and authors, and submitted with the manuscript. Borrowed materials should be acknowledged in the captions in this style: (Reproduced by the kind permission of ? [publishers] from ? [reference]'. Elsevier has preprinted forms for use by authors in these cases: email healthpermissions@elsevier.com
Patient Confidentiality
Where illustrations must include recognisable individuals, living or dead and of whatever age, great care must be taken to ensure that consent for publication has been given. If identifiable features are not essential to the illustration, please indicate where the illustration can be cropped. In cases where consent has not been obtained, it may be necessary to retouch the illustration to mask the eyes and otherwise render the individual 'officially unrecognisable'.
Tables
These should be double spaced and contain only horizontal rules. Do not submit tables as photographs. A short descriptive title should appear above each table and any footnotes, suitably identified, below. Care must be taken to ensure that all units are included. Ensure that each table is cited in the text.
Preparation of Supplementary Data
Elsevier now accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our Author Gateway at http://authors.elsevier.com.
Units & Abbreviations
Avoid abbreviations in the title and abstract. All unusual abbreviations should be fully explained at their first occurrence in the text. All measurements should be expressed in SI units. Imperial units are acceptable from USA contributors.
Copyright Information
Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright see http://authors.elsevier.com). This transfer will ensure the widest possible dissemination of information.
Proofs
Page proofs are emailed to the corresponding author as PDFs for checking. Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. Therefore it is important to ensure that all of your corrections are returned in one all-inclusive email or fax as quickly as possible. Subsequent additional corrections will not be possible, so please ensure that your first communication is complete.
Offprints
Twenty-five offprints are supplied to the corresponding author free of charge. For additional copies, an offprint order form will be sent to the author with the page proofs.
Editorial Board
Editor-in-Chief
M. S. Manku
Amarin Neuroscience Ltd, Kings Park House, Laurelhill Business Park, Polmaise Road, Stirling FK7 9JQ, UK
Founding Editor
D. F. Horrobin
Associate Editors
Y. Huang
Columbus, USA
I. Morita
Tokyo, Japan
A. Nicolaou
Bradford, UK
C. Serhan
Boston, USA
P. Sirois
Quebec, Canada
Editorial Advisory Board
C. Agostoni
Milan, Italy
J. P. Arm
Boston, USA
R. R. Brenner
La Plata, Argentina
P. C. Calder
Southampton, UK
R. S. Chapkin
Texas, USA
S. D. Clarke
Austin, USA
S. Cunnane
Toronto, Canada
V. di Marzo
Naples, Italy
A. Duttaroy
Oslo, Norway
T. E. Eling
Nth Carolina, USA
H. R. Herschman
Los Angeles, USA
J. Y. Jeremy
Bristol, UK
M. Kruger
Palmerston North, New Zealand
M. Maes
Maastricht, The Netherlands
D. P. Mikhailidis
London, UK
M. D. Mitchell
Auckland, New Zealand
F. A. J. Muskiet
Groningen, Germany
R. M. Nusing
Marburg, Germany
E. H. Oliw
Uppsala, Sweden
T. Shimizu
Tokyo, Japan
H. Sinzinger
Vienna, Austria
Y. Urade
Osaka, Japan
J. K. Yao
Pittsburgh, USA
|
刊名字顺( Alphabetical List of Journals):
返回页首 